Skip to main content

Advertisement

ADVERTISEMENT

News

News
09/22/2021
A single-center, prospective, randomized trial suggests that EVLA using a 1470-nm laser with a bare fiber provided outcomes in the short term similar to those using a radial fiber.
A single-center, prospective, randomized trial suggests that EVLA using a 1470-nm laser with a bare fiber provided outcomes in the short term similar to those using a radial fiber.
A single-center, prospective,...
09/22/2021
Vascular Disease Management

Advertisement

News
09/21/2021
Renowned interventional oncology researcher and professor to spearhead editorial efforts of leading educational news source.
Renowned interventional oncology researcher and professor to spearhead editorial efforts of leading educational news source.
Renowned interventional oncology...
09/21/2021
IO Learning
News
09/17/2021
Annual Scientific Symposium Will Take Place November 4-6, 2021   NEW YORK – September 16, 2021 – The Cardiovascular Research Foundation (CRF) has announced 22 late-breaking trial and science presentations that will be reported at...
Annual Scientific Symposium Will Take Place November 4-6, 2021   NEW YORK – September 16, 2021 – The Cardiovascular Research Foundation (CRF) has announced 22 late-breaking trial and science presentations that will be reported at...
Annual Scientific Symposium Will...
09/17/2021
Cath Lab Digest
News
09/14/2021
RDN Position Paper Published in Journal of Hypertension in Light of Growing Clinical Evidence ATHENS, Greece, Sept. 14, 2021 — European Society of Hypertension (ESH), the leading hypertension (HTN) society in...
RDN Position Paper Published in Journal of Hypertension in Light of Growing Clinical Evidence ATHENS, Greece, Sept. 14, 2021 — European Society of Hypertension (ESH), the leading hypertension (HTN) society in...
RDN Position Paper Published in...
09/14/2021
Cath Lab Digest

Advertisement

News
09/14/2021
Funds will support the company’s mission of advancing noninvasive treatment options for people with reduced tissue perfusion September 14, 2021, IRVINE, Calif.--Vibrato Medical, an innovator in the treatment of peripheral arterial...
Funds will support the company’s mission of advancing noninvasive treatment options for people with reduced tissue perfusion September 14, 2021, IRVINE, Calif.--Vibrato Medical, an innovator in the treatment of peripheral arterial...
Funds will support the...
09/14/2021
Vascular Disease Management
News
09/13/2021
September 13, 2021 — ABILITY Diabetes Global (Randomized Comparison of Abluminus DES+ Sirolimus-Eluting Stents versus Everolimus-Eluting Stents in Coronary Artery Disease Patients with Diabetes Mellitus Global) started off with the index...
September 13, 2021 — ABILITY Diabetes Global (Randomized Comparison of Abluminus DES+ Sirolimus-Eluting Stents versus Everolimus-Eluting Stents in Coronary Artery Disease Patients with Diabetes Mellitus Global) started off with the index...
September 13, 2021...
09/13/2021
Cath Lab Digest
News
09/07/2021
September 7, 2021: Medtronic launches the 200 mm and 250mm IN.PACT™  Admiral™ drug-coated balloon (DCB) in Europe after receiving CE (Conformité Européene) Mark. The product is intended to treat long complex femoropopliteal lesions...
September 7, 2021: Medtronic launches the 200 mm and 250mm IN.PACT™  Admiral™ drug-coated balloon (DCB) in Europe after receiving CE (Conformité Européene) Mark. The product is intended to treat long complex femoropopliteal lesions...
September 7, 2021: Medtronic...
09/07/2021
Cath Lab Digest

Advertisement

News
09/02/2021
Rosemont, Illinois, September 2, 2021 – Results of a database review of more than 500,000 abdominal aortic aneurysm (AAA) repairs revealed the majority of patients treated for rupture did not meet the criteria for aneurysm screening. These...
Rosemont, Illinois, September 2, 2021 – Results of a database review of more than 500,000 abdominal aortic aneurysm (AAA) repairs revealed the majority of patients treated for rupture did not meet the criteria for aneurysm screening. These...
Rosemont, Illinois, September 2,...
09/02/2021
Vascular Disease Management
News
09/02/2021
Acquisition builds upon Abbott’s leading vascular portfolio, adding mechanical thrombectomy devices for treating patients with peripheral blood clots ABBOTT PARK, Ill., Sept. 2, 2021 — Abbott announced that it has acquired Walk Vascular,...
Acquisition builds upon Abbott’s leading vascular portfolio, adding mechanical thrombectomy devices for treating patients with peripheral blood clots ABBOTT PARK, Ill., Sept. 2, 2021 — Abbott announced that it has acquired Walk Vascular,...
Acquisition builds upon Abbott’s...
09/02/2021
Vascular Disease Management
News
08/30/2021
FIDELITY analysis presented in a Hot Line Session today at ESC Congress 2021
FIDELITY analysis presented in a Hot Line Session today at ESC Congress 2021
FIDELITY analysis presented in a...
08/30/2021
Cath Lab Digest

Advertisement

Advertisement